LongevityInvestigational

Vilon (Lys-Glu)

Subcutaneous injection, Oral

Overview

Vilon is a synthetic dipeptide consisting of lysine and glutamic acid (Lys-Glu) developed as part of the Khavinson bioregulator peptide research program. The peptide is proposed to interact with DNA regulatory regions to modulate gene expression related to immune function and cellular repair.

Mechanism of Action

Vilon has been studied primarily in Russian research for immunomodulation and potential geroprotective properties. The mechanism is postulated to involve epigenetic regulation, though detailed molecular characterization remains incomplete..

Research Summary & Key Findings

Preclinical studies in rodents have reported that Vilon administration increases lifespan and enhances immune parameters in aging animals. Published clinical evidence is limited to small studies in Russian journals describing immunological effects in elderly subjects, without large randomized controlled trials. Independent replication and validation in international peer-reviewed settings have not been performed, and Vilon lacks regulatory approval outside of Russia.

Clinical Status

Investigational

Vilon (Lys-Glu) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injectionOral

Related Peptides in Longevity

Epithalon (Epitalon)

Research Phase

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epitha...

View details

MOTS-c

Research Phase

A mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. MOTS-c is a 16-amino acid peptide tha...

View details

Humanin

Research Phase

A 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cy...

View details

NAD+ Precursors (NMN)

In Clinical Trials

Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coen...

View details

Find a Provider

Find a verified provider who offers Vilon (Lys-Glu) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Vilon (Lys-Glu).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.